We serve Chemical Name:N-Methyl-N-nitrosoethanamine CAS:10595-95-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:N-Methyl-N-nitrosoethanamine
CAS.NO:10595-95-6
Synonyms:n-nitroso-methyl-ethylamine;Ethanamine, N-methyl-N-nitroso-;N-Methyl-N-nitrosoethanamine
Molecular Formula:C3H8N2O
Molecular Weight:88.108
HS Code:2928000090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:154.4±9.0 °C at 760 mmHg
Density:1.0±0.1 g/cm3
Index of Refraction:1.436
PSA:32.67000
Exact Mass:88.063660
LogP:-0.11
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 2810
Packing Group:III
Contact us for information like n-nitroso-methyl-ethylamine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,N-Methyl-N-nitrosoethanamine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,N-Methyl-N-nitrosoethanamine Use and application,Ethanamine, N-methyl-N-nitroso- technical grade,usp/ep/jp grade.
Related News: China considers self-ruled Taiwan to be part of its territory and has long sought to limit its diplomatic relations and recognition at international bodies such as the W.H.O. N-Methyl-N-nitrosoethanamine manufacturer Novak noted that the research team did see some improvement in standard brain function tests given to a smaller group of trial participants who had actually been diagnosed with Alzheimer’s. N-Methyl-N-nitrosoethanamine supplier Toxic forever chemicals have no place in personal care products,” Scott Faber, EWG’s senior vice president of government affairs. “PFAS have been linked to serious health problems, including cancer and harm to the reproductive and immune systems. EWG applauds Sen. Collins and Rep. Dingell for introducing the No PFAS in Cosmetics Act. N-Methyl-N-nitrosoethanamine vendor The cell product candidate is being developed under a collaboration with Memorial Sloan Kettering Cancer Center (MSK) led by Michel Sadelain, MD, PhD. N-Methyl-N-nitrosoethanamine factory The cell product candidate is being developed under a collaboration with Memorial Sloan Kettering Cancer Center (MSK) led by Michel Sadelain, MD, PhD.
